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 Abstract
Allergens come into contact with the immune system as components of a very diverse mixture. The most common sources are pollen 
grains, food, and waste. These sources contain a variety of immunomodulatory components that play a key role in the induction of allergic 
sensitization. The way allergen molecules bind to the cells of the immune system can determine the immune response. In order to better 
understand how allergic sensitization is triggered, we review the molecular mechanisms involved in the development of allergy and the 
role of immunomodulators in allergen recognition by innate cells.
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 Resumen
Los alérgenos entran en contacto con el sistema inmune como parte de una mezcla heterogénea de compuestos de muy diversa naturaleza. 
Las fuentes de alérgenos más comunes son los granos de polen, alimentos o restos de animales. Estas fuentes contienen una variedad 
de componentes inmunomoduladores que pueden desempeñar un papel importante en la inducción de la sensibilización alérgica. La 
unión de estas moléculas a las células inmunes pueden influir en el resultado inmunológico final. Actualmente, nuestro objetivo es revisar 
los mecanismos moleculares implicados en el desarrollo de la alergia, y el papel de estos inmunomoduladores en el reconocimiento de 
alérgenos por las células innatas, que es clave para entender cómo la sensibilización alérgica se desencadena.
Palabras clave: Sistema immune innato. Alergia. Alérgenos.
Introduction
The immune response results from the sequential activation 
of multiple components of the innate and the adaptive immune 
systems. These components are organized into 3 groups: 
1) physical barriers (skin and mucosal surfaces); 2) the innate 
immune system, which responds to pathogen-associated molecular 
patterns and includes epithelial, endothelial, stromal, and 
phagocytic cells (dendritic cells [DCs], neutrophils, monocytes/
macrophages, and eosinophils), as well as natural killer (NK) 
cells and the complement system; and 3) the adaptive immune 
system, which is induced by DCs priming T and B lymphocytes 
to secrete specific cytokines that shape the immune response [1].
Innate Immune Signaling During the 
Allergic Response
The immune system is regulated to protect the host from 
exaggerated stimulatory signals, thus establishing a state of 
tolerance in healthy individuals. The imbalance arising between 
immunoregulatory mechanisms and effector mechanisms 
results in inflammation, allergy, and autoimmune disorders in 
genetically predisposed persons under specific environmental 
conditions. Although a variety of immunologic mechanisms 
are involved in the pathogenesis of allergy, most allergens 
trigger allergic manifestations through type I hypersensitivity 
reactions, which are characterized by IgE production [2]. 
Several immune cells are involved in the development 
of the innate immune response during allergic inflammation. 
Mast cells and basophils are responsible for anaphylaxis, 
asthma, and other allergic disorders [2]. Both cell types share 
numerous common features such as secretion of mediators 
(histamines, leukotrienes, and TH2 cytokines), and expression 
of toll-like receptors (TLRs) and complement receptors. In 
allergic individuals, the high-affinity IgE receptor on these 
cells (also known as Fc epsilon receptor I) is almost fully 
saturated with IgE and essentially primed and ready to initiate 
IgE-mediated responses when it encounters a sufficient 
quantity of allergen [3,4]. 
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have resulted in the separation of the immune system from 
positive exposure to microbes early in life [18]. Consequently, 
immunoregulatory mechanisms remain underdeveloped, and 
an imbalance in immune homeostasis predisposes to TH2 
immune responses favoring allergic processes [19]. 
A critical event in the development of atopy seems to be 
the absence of a switch from the predominant TH2 response 
observed in all newborns to an immune state characterized by 
the prevalence of regulatory and/or TH1 responses. In allergic 
patients, fetal primed TH2 immunity tends to persist until later 
in life and to boost TH2 responses upon allergen exposure [20].
Epigenetic Modifications
The many genome-wide association studies conducted for 
asthma [21] and other allergic phenotypes [22] have identified 
hundreds of genes associated with allergic diseases. However, 
most only confer a small increased risk and do not correspond 
to the various phenotypes [23]. 
One possible explanation could be gene–environment 
interactions, which are thought to be mediated by epigenetic 
mechanisms. There are several examples of the association 
between environmental exposure and epigenetic modifications 
in allergic diseases. The best-known examples are probably 
those of exposure to a farm environment and smoking. A meta-
analysis of 29 studies found a 25% lower prevalence of childhood 
asthma in patients exposed to a farm environment [24]; even in 
utero farm exposure is protective against hay fever, asthma, and 
eczema [25]. Likewise, levels of DNA methylation of several 
asthma-associated genes in the cord blood of newborns differ 
between children who have and have not been exposed to a 
farm environment [26]. Moreover, it has been reported that 
methylation of CD14 promoter in placenta is altered if the 
mother lives on a farm [27].
Maternal smoking during pregnancy is associated with 
allergic diseases [28,29]. Additionally, the risk of asthma is 
increased in children whose maternal grandmother smoked 
during their mother’s fetal period [30].
Other examples of gene–environment interactions in 
allergic diseases include exposure to air pollution, which has 
been reported to worsen the severity of asthma [31], and the 
epigenetic modifications induced by rhinovirus infections in 
the nasal epithelial cells of asthma patients [32].
Recent research has revealed that several asthma- and 
allergy-related genes are epigenetically regulated; for example, 
STAT6 and FOXP3 are regulated by DNA methylation [33,34], 
and the transcription of IL13 is regulated by histone 
acetylation [35].
It is evident that more research is needed to establish the 
association between allergy-related diseases and epigenetics.
Proteolytic Activity
The role of endogenous and exogenous proteases in airway 
inflammation and remodeling has been the subject of active 
research during recent decades. Direct cleavage of tight junctions 
and signaling of specific receptors (protease-activated receptors) 
have been reported to be involved in inflammatory processes [36]. 
Human respiratory viruses have been associated with an 
increased risk of asthma [37,38]. Respiratory syncytial virus 
Eosinophils are also relevant in the development of 
allergic responses. These cells usually accumulate in mucosal 
tissue during allergen-induced inflammation. The reaction 
is due to IL-5, the eosinophilic factor responsible for the 
proliferation and differentiation of these cells. It is secreted 
mainly by TH2 cells. Additionally, granulocyte macrophage 
colony-stimulating factor (GM-CSF) produced by epithelial 
cells seems to have a role in the activation and recruitment of 
eosinophils in tissue [5].
Epithelial cells are the interface between the host and 
the environment and act as the first line of defense against 
microorganisms, gases, and allergens [6]. The activation of 
pattern recognition receptors on epithelial cells in the airways 
or in the gut leads to the release of cytokines (IL-25, IL-33, 
and thymic stromal lymphopoietin) that attract and activate 
innate and adaptive immune cells. These cytokines have been 
shown to function upstream of classic TH2 cytokines, thus 
providing a molecular mechanism by which epithelial cells 
directly affect TH2-induced immunity [7]. This is a key process 
in the recognition of inhaled/ingested allergens that activate 
the local network of DCs, which coordinates the subsequent 
immune response [8].
DCs provide an important bridge between the innate and 
the adaptive immune systems by processing antigens and 
presenting them to T cells. They are found in an immature state 
in tissue, but upon antigen uptake, they migrate to the draining 
lymph nodes where they present the antigens to T cells. This 
process induces the release of signature cytokines (IL-4, IL-12, 
and IFN-g), which drive T-cell polarization during allergic 
inflammation [9-12].
Finally, NK cells are major producers of an array of 
proinflammatory and immunosuppressive cytokines such 
as IFN-g, TNF-a, and IL-10. These cells include a recently 
identified lineage, the invariant NK T cells (iNKTs), which 
are characterized by the expression of a limited repertoire 
of T-cell receptors and the production of large amounts of 
cytokines (IFN-g, IL-4, IL-5, and IL-13) [13-14]. Likewise, 
innate lymphoid cells (ILCs) are a recently discovered 
innate cell population, of which 3 subpopulations have been 
described, namely, ILC1 (predominantly expressing IFN-g), 
ILC2 (expressing IL-5, IL-9, and IL-13), and ILC3 (expressing 
IL-22 and/or IL-17) [13]. ILC2s are TH2 cytokine–producing 
cells that were initially identified in the gastrointestinal track, 
lung, nasal polyp tissue, and blood and are reported to have a 
potential role in allergic inflammation [14].
Factors Involved in Deviation of the 
Allergic Innate Immune Response 
The main causes of allergy are genetic factors, 
environmental exposure, and the interaction between both [15]. 
Several epidemiological reports have indicated an association 
between the increasing incidence of allergic diseases in 
developed countries and improved health care and lifestyle 
conditions, which result in a substantial loss of early microbial 
stimulation [16], thus supporting the hygiene hypothesis [17]. 
According to this theory, increasingly hygienic living 
conditions, use of antibiotics, and sterile food preparation 
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was recently shown to upregulate matrix metalloproteinase 10, 
thus suggesting a role for endogenous proteases in the 
onset of asthma [39,40]. Protease-activated receptors are 
upregulated in other inflammatory diseases, such as chronic 
rhinosinusitis [41]. 
Since the discovery of the cysteine protease activity of 
the major allergen Der p 1 [42], several mite allergens have 
been identified as proteases. Mite allergy is the most prevalent 
allergic disease worldwide. Several publications report that 
mite proteases mediate inflammatory mechanisms [36,37,43]; 
however, allergen exposure is caused by mite feces, an 
extremely effective platform where proteases interact with 
innate proinflammatory signaling [44]. In addition to mites, 
fungal and insect allergens, such as those of Alternaria [45,46], 
Aspergillus [47], and cockroach [48], have been reported to 
induce protease-mediated allergic inflammation. All of these 
allergens seem to drive allergic sensitization in areas with low 
exposure to mite allergen.
First described a decade ago [49], IL-33 exerts its function 
through the specific ST2 receptor that is present in TH2 cells. 
IL-33 exerts a dual function, namely, an anti-inflammatory 
function when released from apoptotic cells, as it is inactivated 
by caspases, and a proinflammatory function when released 
from necrotic cells. iNKTs produce IL-4 in the presence of 
IL-33 and α-galactosylceramide [50], and ILC2s, which also 
express ST2, produce TH2 cytokines in response to IL-33 [51]. 
In a TH2-skewed immune system, IL-33 will thus promote 
allergic sensitization. Both mites [52] and Alternaria [53,54] 
have been reported to induce IL-33 production. 
These findings show that early intervention strategies 
in viral infections [55,56], blockade of cystein protease 
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Figure. Interactions between innate immune cells in allergic diseases. TSLP indicates thymic stromal lymphopoietin; ILC, innate lymphoid cell; PG, 
prostaglandin; LT, leukotriene.
activity [57], and mite-specific immunotherapy in sensitized 
subjects [58] could constitute novel approaches for the 
prevention of asthma.
House Dust Mite Major Group 1 Allergens as a 
Model 
The protease activity of house dust mite major group 1 
allergens (Der f 1 and Der p 1), two of the most important 
allergens worldwide, has been shown to cause barrier 
dysfunction, induce production of proinflammatory cytokines 
by epithelial cells and keratinocytes, cleave various molecules, 
modulate functions of several cell types, and induce TH2 
responses [57]. 
The repeated exposure of airway mucosa to cysteine protease 
allergens such as Der p 1 and Der f 1 results in lung eosinophilia 
and serum IgE/IgG1 production in a manner dependent on the 
protease activity of the allergen, primarily with the cooperation 
of adaptive immune cells and IL-33–responsive innate cells [59]. 
Der p 1 can efficiently activate the Drosophila innate immune 
system in terms of both epithelial and systemic responses. 
These responses depend on the activation of the transcription 
factor NF-κB. In addition, Der p 1 cleaved the ectodomain of 
peptidoglycan recognition protein LC, thus activating the innate 
immune response. 
Furthermore, interaction of Der p 1 with respiratory 
epithelium caused rapid secretion of CCL20 and thymic 
stromal lymphopoietin, thus inducing recruitment of immature 
DCs to the lung. This response was dependent on the presence 
of b-glycan structures in Der p 1 [60,61]. Accordingly, the 
deglycosylated preparation of Der p 1 exhibited minimal uptake 
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retinoic acid and 18-carbon chain fatty acids bind within 
this cavity [75-77], while longer chain and complex lipids, 
especially with polar groups, must be extruded from the cavity. 
Lipocalins can also bind directly to cellular receptors such 
as type 1 and 2 lipocalin receptors and TLRs [78,79], thus 
mediating their endocytosis. 
The salivary lipocalins Equ c 1 [80], Fel d 4 [81], and 
Can f 6 [82] and the structurally related major urinary proteins, 
such as mouse Mus m 1 [83], induce IgE responses. They can 
bind small volatile compounds such as odorants, pheromones, 
and sex steroids [84], thus enabling them to enhance TLR4-
dependent lipopolysaccharide signalling [85]. 
Another example of lipocalin-binding lipids is the major 
mammalian allergen b-lactoglobulin, milk lipocalin, which 
can interact with membrane phospholipids, thus disrupting 
structure and exposing hydrophobic residues [86,87]. 
Nonspecific Lipid Transfer Proteins
nsLTPs are important allergens for fruits (Pru  p 3), 
vegetables and nuts (Cas s 8), and aeroallergens, such as 
Par j 1 from Parietaria judaica pollen and Ole e 7 from 
Olea europaea [88,89]. They have a tunnel-like cavity 
that can accommodate phospholipids, glycolipids, with 
and fatty acids [90,91]. nsLTPs can transfer phospholipids 
and glycolipids between plant organelles [92] and present 
antimicrobial activity resulting from their interaction with 
and permeabilization of biological membranes [93]. Ligands 
transported by allergenic LTPs can contribute to the activation 
of innate immune cells, although there is little experimental 
evidence of this [94].
Tordesillas et al [95] showed that the peach nsLTP Pru p 3 
can cross the monolayer formed by Caco-2 epithelial cells 
through the endocytic pathway by means of lipid rafts and 
caveolar endocytosis. The authors also reported that the lower 
transport rate of a hypoallergenic peach nsLTP was associated 
with significantly lower expression of TH2-related cytokines 
compared with Pru p 3.
Par j 1 has been reported to function as an activator of the 
immune system by inducing IFN-γ production by NK cells 
exclusively in healthy individuals [96].
2S albumins
2S albumins, which are defined based on their sedimentation 
coefficient, constitute a major group of seed storage proteins 
that are widely distributed in both monocotyledonous and 
dicotyledonous plants. They are embedded in the protein 
bodies of developing seeds and are utilized by the plant as a 
source of nutrients (amino acids and carbon skeletons) during 
germination and seedling growth [97]. 
2S albumins adopt a common and compact 3-dimensional 
structural scaffold comprising a bundle of 5 α-helices in 
different regions and a C-terminal loop folded in a right-handed 
super helix stabilized by 4 conserved disulfide bonds [98]. In 
general, 2S albumins can bind lipids, as has been demonstrated 
for Sin a 1 from yellow mustard and various 2S albumin 
isoforms from sunflower seeds [99]. The 2S albumin from 
Brazil nut, Ber e 1, has a potential lipid-binding hydrophobic 
cavity of the same size as that of nsLTPs [100,101]. Ber e 1 was 
by DCs [61]. The recognition of this allergen would then be 
mediated by specific glycan receptors such as the DC-specific 
intercellular adhesion molecule-3-grabbing nonintegrin [62]. 
The carbohydrate moieties on these allergens played a vital role 
in recognition by innate immune cells, resulting in downstream 
deleterious TH2 cell activation and IgE production [63].
Lipid Ligands 
Allergens are never delivered to the immune system in a 
pure form but are contained in allergen sources such as pollen 
grains, food matrices, or fecal particles. In order to assess 
the presence of lipid immunomodulators in pollen allergens, 
Bashir et al [64] performed a lipidomic analysis of pollen 
from 22 species and established a database of lipid antigens as 
new candidate molecules involved in allergy. Cypress pollen 
contains phosphatidylcholine and phosphatidylethanolamine 
on the surface of its grains. This finding seems to be relevant 
for the activation of DCs by CD1 molecules and the subsequent 
stimulation of T-cell proliferation in patients with cypress 
pollen allergy [64]. 
Moreover, a recent study of the general ability of olive 
pollen lipids to activate DCs and stimulate iNKT cells in healthy 
individuals showed that polar lipids (eg diacylglycerols, free 
fatty acids, and triacylglycerols) isolated from olive pollen 
grains upregulated CD1d on DCs and iNKT cells in coculture 
experiments [65].
Taken together, these results show that lipids play a role 
in the early stages of allergic sensitization by interacting with 
several components of the innate immune system, such as those 
involving TLRs or CD1d.
ML-Domain Lipid-Binding Proteins
Allergenic proteins commonly have lipid-binding 
properties, implying that the intrinsic biological function 
contributes to allergenic activity. The group 2 house dust 
mite allergens (Der f 2 and Der p 2) are homologs of the 
ML-domain protein MD-2, the lipopolysaccharide-binding 
component of the TLR 4 signalling complex, for innate 
immune signalling [66]. HEK293 cells transfected with Der p  2 
did not require MD-2 to bind and induce a TLR4-mediated 
response [66], although induction was weaker. However, IL-8 
production was increased 30-fold when Der p 2 was transfected 
into MD-2 cells, possibly owing to an additive effect. Der p 2 
can also stimulate proinflammatory cytokine secretion from 
epithelial cells [66,67]. 
Der p 2 local inflammatory responses in the airway 
epithelium are primarily mediated by airway smooth muscle 
cells. The response includes activation of the MyD88 
signalling pathway via TLR2, downstream signalling of NF-κB 
activation, and production of high levels of proinflammatory 
cytokines [68,69].
Lipocalins
The lipocalin family is complex and includes both animal 
and bacterial allergens [70,71], although its presence in the 
plant kingdom cannot be ruled out [72]. 
Lipocalins have a characteristic fold enclosing a 
hydrophobic ligand-binding site [73,74]. Ligands such as 
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not able to induce production of IgE or IgG in mice, although 
it was able to induce production of both antibodies when 
administered with sterol-rich or polar lipid fractions isolated 
from Brazil nuts. The response comprised a cooperative effect 
between Ber e 1 and b-sitosterol and glycolipid-rich fractions 
and was partially dependent on iNKT cells  [101].
Bet v 1-like protein
Bet v 1 from the pathogenesis-related (PR) 10 family is 
the major allergen of birch pollen. PR-10 proteins are also the 
principal allergens for other Fagales trees, such as Cor a 1 
and Aln g 1 from hazel and alder and food allergens such as 
Mal d 1 from apple. The PR-10 protein fold creates a large 
hydrophobic pocket that can carry or store many ligands 
(including flavonoids) and fatty acids [102]. The natural 
ligand for the main isoform of Bet v 1 is now known to be the 
flavonoid glycoside quercetin-3-O-sophoroside [102], which 
requires both the glycan and the lipid fractions for binding. 
Curiously, different isoforms of Bet v 1 can be found in pollen 
and share 95% amino acid sequence identity. By contrast, not 
all show the same IgE-binding capacity, and the difference lies 
in the ligands they can bind.
Concluding Remarks
Despite much research on allergen characterization and 
the interaction of allergens with the immune system, we are 
still far from fully understanding how allergic responses are 
triggered and what defines the final outcome of this response. 
In fact, as shown in this review, many of the factors involved 
in allergy are either intrinsic to the allergen and its properties 
(proteolytic activity, ligand binding) or associated with the 
host environment (epigenetic modifications, new types of 
immune cells). These factors can skew the immune system 
towards an allergic response. Extensive research on innate 
immune responses during allergic sensitization will help us 
to characterize the “decision-making process” that takes place 
when the immune system encounters an allergenic antigen.  
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